Childhood cancer: the improving prognosis.
D001215:Asparaginase / Q000627:therapeutic use; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D003596:Cytosine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008223:Lymphoma / Q000188:drug therapy; D008558:Melphalan / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009369:Neoplasms / Q000628:therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D012516:Osteosarcoma / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011379:Prognosis; D012075:Remission, Spontaneous; D012208:Rhabdomyosarcoma / Q000188:drug therapy; D013713:Teniposide / Q000627:therapeutic use; D013866:Thioguanine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use; D009396:Wilms Tumor / Q000188:drug therapy
D009588:Nitrogen Mustard Compounds; D011344:Procarbazine; D014750:Vincristine; D004317:Doxorubicin; D003596:Cytosine; D003520:Cyclophosphamide; D013713:Teniposide; D015122:Mercaptopurine; D001215:Asparaginase; D013866:Thioguanine; D008558:Melphalan; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin